Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Brest
Study EFS in patients with melanoma or NSCLC treated by immunotherapy (anti CTLA4 or anti PDL1) and performed18FDG PET
Multicentric retrospective study
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients treated for melanoma or NSCLC with immunotherapy (anti CTLA4 or antiPDL1)
patients treated in Brest, Morlaix, Landerneau hospital
patients performed FDG PET
no opposition to study
You may not be if
age under 18 years old
refusal to participate
Clareo Health | 18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
